Question of the Day: 4/22/2013 Is the fact that a "mom and pop" compounding pharmacy has become extremely wealthy((NECC type wealthy) from compounding and solely from compounding a strong indicator that the "mom and pop" is really manufacturing?

So shouldn't the FDA and state boards of pharmacy being looking at all compounding pharmacies' tax returns and financial records?   Are is that going to the extreme?  Should we simply look to the volume produced and sold for deteriming who is high risk and needs to be immediately inspected and closely watched.  What if the company is simply mass producing but doing it in volumes of 10-12 injectibles at a time so as to try to go unnoticed?  However, that mom and pop pharmacies actually produces more preparations and makes more money than NECC did?  What about the mom and pop compound pharmacy who does everything right, buys the right powders, test, etc, and has to charge a higher price for the same product to make a profit even though it is a smaller profit that another company?  So do we look at gross profit or net profit, or both?   How does the FDA and the state boards of pharmacy catch those high risk compounders that might not otherwise be on the radar?